806
Views
12
CrossRef citations to date
0
Altmetric
Research Article

New coumarin derivatives as carbonic anhydrase inhibitors

, , , , , , & show all
Pages 192-198 | Received 29 Jan 2013, Accepted 04 Mar 2013, Published online: 08 May 2013

References

  • Anand P, Singh B, Singh N. 2012. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Med Chem. 20:1175–1180.
  • Arslan O, Nalbantoglu B, Demir N, Ozdemir H, Küfrevioglu OI. 1996. A new method for the purification of carbonic anhydrase isozymes by affinity chromatography. Turk J Med Sci. 26:163–166.
  • Arslan M, Gencer N, Arslan O, Guler OO. 2012. In vitro efficacy of some cattle drugs on bovine serum paraoxonase 1 (PON1) activity. J Enzyme Inhib and Med Chem. 27:722–729.
  • Ashida M, Brey P. 1995. Role of the integument in insect defense: pro-phenol oxidase cascade in the cuticular matrix. Proc Natl Acad Sci USA. 92:10698–10702.
  • Aydemir T, Kavrayan D. 2009. Purification and characterization of glutathione-s-transferase from chicken erythrocyte. Artif Cells Blood Substit Immobil Biotechnol. 37:92–100.
  • Bayram T, Arslan O, Ugras HI, Cakir U, Ozensoy O. 2007. Purification of carbonic anhydrase from dog erytrocytes and investigation of in vitro inhibition effects by various compounds. J Enzyme Inhib Med Chem. 22:739–744.
  • Borras J, Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT. 1999. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?Bioorg Med Chem. 7: 2397–2406.
  • Bytyqi-Damoni A, Genc H, Zengin M, Beyaztas S, Gencer N, Arslan O. 2012. In vitro effect of novel β-lactam compounds on xanthine oxidase enzyme activity. Artif Cells Blood Substit Immobil Biotechnol. 40:369–377.
  • Carta F, Maresca A, Scozzafava A, Supuran CT. 2012. Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg & Med Chem. 20:2266–2273.
  • Cicek B, Ergun A, Gencer N. 2012. Synthesis and evaluation in vitro effects of some macro cyclic thiocrown ethers on erythrocyte carbonic anhydrase I and II” Asian. J Chem. 24:3729–3731.
  • Demirel LA, Tarhan L. 2004. Dismutation properties of purified and GDA modified CuZnSOD from chicken heart. Artif Cells Blood Substit Immobil Biotechnol. 32:609–624.
  • Demir D, Gencer N, Er A. 2012. Purification and characterization of prophenoloxidase from Galleria mellonella L. Artif Cells Blood Substit Immobil Biotechnol. 40:369–377.
  • Ebbesen P, Pettersen EO, Gorr TA, Jobst G, Williams K, Kienninger J, et al. 2009. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. J Enzyme Inhib Med Chem. 24:1–39.
  • Gencer N, Arslan O. 2011. In Vitro Effects of Some Pesticides on PON1Q192 and PON1R192 Isoenzymes from Human Serum. Fresen Envir Bull. 20:590–596.
  • Gencer N, Ergun A, Demir D. 2012a. In vitro effects of some pesticides on human erythrocyte carbonic anhydrase activity. Fresen Environ Bull. 21:549–552.
  • Gencer N, Ergun A, Demir D. 2012b. In vitro effects of some anabolic compounds on erythrocyte carbonic anhydrase I and II. J Enzyme Inhib and Medicinal Chem. 27:208–210.
  • Gokce B, Gencer N, Arslan O, Turkoglu SA, Alper M, Kockar F. 2012. Evaluation of in vitro effects of some analgesic drugs on erythrocyte and recombinant carbonic anhydrase I and II. J Enzyme Inhib Med Chem. 27: 37–42.
  • Gumus A, Karadeniz S, Ugras HI, Bulut M, Cakir U, Gören AC. 2010. Synthesis, complexation, and biological activity studies of 4-aminomethyl-7,8-dihydroxy coumarines and their crown ether derivatives. J Heteroc Chem. 47:1127–1133.
  • Gupta SP, Kumaran S. 2005. A quantitative structure–activity relationship study on some aromatic/heterocyclic sulfonamides and their charged derivatives acting as carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem. 20:251–259.
  • Hindi KM, Panzenr MJ, Tessier CA, Cannon CL, Youngs WJ. 2009. The medicinal applications of imidazolium carbene-metal complexes. Chem Rev. 109:3859–3884.
  • Karatas MO, Alici B, Cakir U, Cetinkaya E, Demir D, Ergun A, Gencer N, Arslan O. 2013. Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives. J Enzyme Inhib Med Chem. 28:317–322.
  • Khan KM, Shah Z, Ahmad VU, Ambreen N, Khan M, Taha M, et al. (2012). 6-Nitrobenzimidazole derivatives: potential phosphodiesterase inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem. 20:1521–1526.
  • Lehtonen J, Shen B, Vihinen M, Casini A, Scozzafava A, Supuran CT, et al. 2004. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem. 279:2719–2727.
  • Maren TH. 1960. A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharm Exp Ther. 130:2629–2634.
  • Maresca A, Temperini C, Vu H, Pham NB, Poulsen SA, Scozzafava A, Quinn RJ, Supuran CT. 2009. Nonzinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc. 131:3057–3062.
  • Maresca A, Temperini C, Pochet L, Masereel B, Scozzafava A, Supuran CT. 2010. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem. 53:335–344.
  • McKiernan JM, Buttyan R, Stifelman MD, Kutz AG, Chen MW, Olsson CA, Sawczuk IS. 1997. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res. 57:2362–2365.
  • Nair SK, Ludwig PA, Christianson DW. (1994). 2-site binding of phenol in the active-site of human carbonic-anhydrase-ii - structural implications for substrate association. J Am Chem Soc. 116:3659–3660.
  • Nishimori I. 2004. Acatalytic CAs: carbonic anhydrase-related proteins. In: Supuran CT, Scozzafava A, Conway J, Eds. Carbonic Anhydrase—Its Inhibitors and Activators. Boca Raton (FL) USA: CRC Press, pp. 25–43.
  • Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. 2005a. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. J Med Chem. 48:7860–7866.
  • Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. 2005b. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg Med Chem Lett. 15:3828–3833.
  • Nishimori I, Minakuchia T, Onishia S, Vullob D, Cecchib A, Scozzafavab A, Supuran CT. 2007a. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorg Med Chem. 15: 7229–7236.
  • Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran CT. 2007b. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. J Med Chem. 50:381–388.
  • Ozdemir I, Sahin N, Demir S, Cetinkaya B. 2005. In situ generated 1- alkylbenzimidazole-palladium catalyst for the Suzuki coupling of aryl chlorides. J Molec Catal. 234:181–185.
  • Pastorekova S, Parkkila S, Pastorek J, Supuran CT. 2004. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem. 19:199–229.
  • Sayin D, Cakir DT, Gencer N, Arslan O. 2012. Effects of some metals on Paraoxonase activity from shark Scyliorhinus canicula. J Enzyme Inhib Med Chem. 27:595–598.
  • Scozzafava A, Mastrolorenzo A, Supuran CT. 2006. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Pat. 16:1627–1664.
  • Smith KS, Ferry JG. 2000. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev. 24:335–366.
  • Sonmez F, Sevmezler S, Atahan A, Ceylan M, Demir D, Gencer N, Arslan O, Kucukislamoglu M. 2011. Evaluation of new chalcone derivatives as polyphenol oxidase inhibitors. Bioorg Med Chem Lett. 21:7479–7482.
  • Stams T, Christianson DW. 2000. The carbonic anhydrases—new horizons (Chegwidden WR, Carter ND, Edwards YH, Eds), pp. 159–174.
  • Supuran CT. 2008. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 7:168–181.
  • Supuran CT. 2010. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett. 20:3467–3474.
  • Supuran CT, Scozzafava A, Casini A. 2003. Carbonic anhydrase inhibitors. Med Res Rev. 23:146–189.
  • Temperini C, Innocenti A, Scozzafava A, Parkkila S, Supuran CT. 2010. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors. J Med Chem. 53:850–854.
  • Thiry A, Dogne JM, Masereel B, Supuran CT. 2006. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci. 27:566–573.
  • Tischer M, Pradel G, Ohlsen K, Hilzgrabe U. 2012. Quaternary ammonium salts and their antimicrobial potential: targets or nonspecific interactions?Chem Med Chem. 7:22–31.
  • Vullo D, Franchi M, Gallori E, Pastorek J, Scozzafava A, Pastorekova S, Supuran CT. 2003. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 13:1005–1009.
  • Vullo D, Franchi M, Gallori E, Antel J, Scozzafava A, Supuran CT. 2004. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. J Med Chem. 47:1272–1279.
  • Vullo D, Voipiob J, Innocenti A, Riverab C, Rankib H, Scozzafavaa A, Kailab K, Supuran CT. 2005a. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 15:971–976.
  • Vullo D, Innocenti A, Nishimori I, Pastorek J, Scozzafava A, Pastorekova S, Supuran CT. 2005b. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?Bioorg Med Chem Lett. 15:963–969.
  • Vu H, Pham NB, Quinn RJ. 2008. Direct screening of natural product extracts using mass spectrometry. J Biomol Screen. 13: 265–275.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.